Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,912 | 105 | 97.9% |
| Education | $40.40 | 3 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $684.02 | 34 | $0 (2023) |
| PFIZER INC. | $392.34 | 24 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $195.92 | 10 | $0 (2020) |
| AMAG Pharmaceuticals, Inc. | $95.94 | 4 | $0 (2018) |
| Astellas Pharma US Inc | $89.34 | 6 | $0 (2023) |
| Exeltis, USA Inc. | $78.34 | 5 | $0 (2023) |
| Lupin Inc. | $55.54 | 3 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $54.07 | 4 | $0 (2020) |
| Organon LLC | $45.29 | 2 | $0 (2023) |
| Novo Nordisk Inc | $31.30 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $263.11 | 15 | ABBVIE INC. ($100.92) |
| 2022 | $306.91 | 16 | ABBVIE INC. ($138.69) |
| 2021 | $253.10 | 13 | AbbVie Inc. ($152.56) |
| 2020 | $137.21 | 7 | AbbVie Inc. ($47.01) |
| 2019 | $412.05 | 23 | AbbVie, Inc. ($182.70) |
| 2018 | $247.00 | 13 | PFIZER INC. ($82.41) |
| 2017 | $333.13 | 21 | PFIZER INC. ($145.70) |
All Payment Transactions
108 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Biological | ||||||
| 10/04/2023 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: WOMENS HEALTH | ||||||
| 09/27/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Biological | ||||||
| 09/20/2023 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Oral Contraceptive | ||||||
| 09/13/2023 | Organon LLC | — | Food and Beverage | In-kind items and services | $19.58 | General |
| 08/16/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: HORMONE THERAPY | ||||||
| 08/09/2023 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: WOMENS HEALTH | ||||||
| 06/21/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Biological | ||||||
| 06/08/2023 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Oral Contraceptive | ||||||
| 06/01/2023 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: WOMENS HEALTH | ||||||
| 04/20/2023 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: WOMENS HEALTH | ||||||
| 03/23/2023 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Oral Contraceptive | ||||||
| 03/02/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $16.74 | General |
| 02/23/2023 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: WOMENS HEALTH | ||||||
| 02/09/2023 | Agile Therapeutics, Inc. | Twirla (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Birth Control Contraceptive Patch | ||||||
| 12/08/2022 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: WOMENS HEALTH | ||||||
| 11/30/2022 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Oral Contraceptive | ||||||
| 11/02/2022 | Organon LLC | JADA SYSTEM (Device) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: POSTPARTUM UTERINE HEMORRHAGING | ||||||
| 10/26/2022 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: WOMENS HEALTH | ||||||
| 10/20/2022 | ABBVIE INC. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $6.18 | General |
| Category: WOMENS HEALTH | ||||||
| 09/21/2022 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: WOMENS HEALTH | ||||||
| 08/24/2022 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Urology | ||||||
| 08/17/2022 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: WOMENS HEALTH | ||||||
| 06/15/2022 | CooperSurgical, Inc. | Endosee (Device) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Obstetrics/Gynecology (Women's Health) | ||||||
| 06/08/2022 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Oral Contraceptive | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 170 | 177 | $26,089 | $8,902 |
| 2022 | 4 | 186 | 205 | $28,629 | $10,249 |
| 2021 | 6 | 231 | 248 | $37,286 | $13,102 |
| 2020 | 6 | 218 | 259 | $41,201 | $12,980 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 45 | $7,605 | $2,605 | 34.2% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 50 | 50 | $5,865 | $2,077 | 35.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 52 | 52 | $4,945 | $1,952 | 39.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 18 | $4,590 | $1,511 | 32.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $3,084 | $757.57 | 24.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 70 | $11,830 | $4,325 | 36.6% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 58 | 58 | $6,960 | $2,403 | 34.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 62 | 62 | $6,014 | $2,323 | 38.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 15 | $3,825 | $1,199 | 31.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 55 | 68 | $11,492 | $4,030 | 35.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 25 | 28 | $7,140 | $2,628 | 36.8% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 62 | 62 | $7,440 | $2,607 | 35.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 63 | 63 | $6,111 | $2,389 | 39.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 15 | 15 | $3,855 | $1,057 | 27.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 11 | 12 | $1,248 | $390.90 | 31.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 50 | 79 | $13,351 | $3,819 | 28.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 32 | 42 | $10,710 | $3,011 | 28.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 53 | 53 | $5,141 | $2,080 | 40.5% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 49 | 49 | $5,880 | $2,071 | 35.2% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 23 | 23 | $5,911 | $1,961 | 33.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 11 | 13 | $208.00 | $38.82 | 18.7% |
About Dr. William Jones, M.D
Dr. William Jones, M.D is a Obstetrics & Gynecology healthcare provider based in Wichita Falls, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881672954.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Jones, M.D has received a total of $1,953 in payments from pharmaceutical and medical device companies, with $263.11 received in 2023. These payments were reported across 108 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($1,912).
As a Medicare-enrolled provider, Jones has provided services to 805 Medicare beneficiaries, totaling 889 services with total Medicare billing of $45,234. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Location Wichita Falls, TX
- Active Since 01/09/2006
- Last Updated 04/22/2024
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1881672954
Products in Payments
- Orilissa (Drug) $228.05
- LILETTA (Drug) $209.26
- PREMARIN (Drug) $178.59
- PREMARIN ORALS (Drug) $153.10
- Kyleena (Drug) $143.04
- LO LOESTRIN FE (Drug) $135.50
- INTRAROSA (Drug) $95.94
- ORILISSA (Drug) $94.42
- SLYND (Drug) $78.34
- SOLOSEC (Drug) $55.54
- Mirena (Drug) $52.88
- Veozah (Drug) $46.30
- ESTRING (Drug) $43.85
- Myrbetriq (Drug) $43.04
- MYFEMBREE (Drug) $33.72
- Saxenda (Drug) $31.30
- NUVARING (Drug) $28.27
- JADA SYSTEM (Device) $25.71
- ACCRUFER (Drug) $24.29
- Axonics (Device) $20.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Wichita Falls
Gradie Moore, M.d, M.D
Obstetrics & Gynecology — Payments: $2,914
Dr. Jasbir Ahluwalia, M.d, M.D
Obstetrics & Gynecology — Payments: $2,568
Dr. Steven Godfrey, M.d, M.D
Obstetrics & Gynecology — Payments: $2,483
James Van Riper, D.o, D.O
Obstetrics & Gynecology — Payments: $2,096
Dr. Ryan Bannon, M.d, M.D
Obstetrics & Gynecology — Payments: $1,083
Mrs. Mandy Winfrey, M.d, M.D
Obstetrics & Gynecology — Payments: $961.26